Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Adler

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Nature Communications|April 12, 2013
VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formationMakoto Hayashi, Arindam Majumdar, Xiujuan Li, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 2, 2026
Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI studySteven J Steiner, Jeremy Adler, Shehzad A Saeed, et al.
Inflammatory Bowel Diseases|December 6, 2021
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVIDKimberly N Weaver, Xian Zhang, Xiangfeng Dai, et al.
Inflammatory Bowel Diseases|May 13, 2024
MRI and Blood-based Biomarkers Are Associated With Surgery in Children and Adults With Ileal Crohn's DiseaseJonathan R Dillman, Jean A Tkach, Joel G Fletcher, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 1, 2026
Reshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paperDan Turner, Amit Assa, Mikkel Malham, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2024
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel diseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Inflammatory Bowel Diseases|July 13, 2022
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel DiseaseKimberly N Weaver, Xian Zhang, Xiangfeng Dai, et al.
The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Pediatrics|June 18, 2014
Effectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health systemChristopher B Forrest, Wallace V Crandall, L Charles Bailey, et al.
Inflammatory Bowel Diseases|December 31, 2020
Development and Testing of a New Simplified Endoscopic Mucosal Assessment for Crohn's Disease: The SEMA-CDJeremy Adler, Sally J Eder, Acham Gebremariam, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Nature Communications|April 12, 2013
VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formationMakoto Hayashi, Arindam Majumdar, Xiujuan Li, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 2, 2026
Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI studySteven J Steiner, Jeremy Adler, Shehzad A Saeed, et al.
Inflammatory Bowel Diseases|December 6, 2021
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVIDKimberly N Weaver, Xian Zhang, Xiangfeng Dai, et al.
Inflammatory Bowel Diseases|May 13, 2024
MRI and Blood-based Biomarkers Are Associated With Surgery in Children and Adults With Ileal Crohn's DiseaseJonathan R Dillman, Jean A Tkach, Joel G Fletcher, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 1, 2026
Reshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paperDan Turner, Amit Assa, Mikkel Malham, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2024
Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel diseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Inflammatory Bowel Diseases|July 13, 2022
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel DiseaseKimberly N Weaver, Xian Zhang, Xiangfeng Dai, et al.
The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Pediatrics|June 18, 2014
Effectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health systemChristopher B Forrest, Wallace V Crandall, L Charles Bailey, et al.
Inflammatory Bowel Diseases|December 31, 2020
Development and Testing of a New Simplified Endoscopic Mucosal Assessment for Crohn's Disease: The SEMA-CDJeremy Adler, Sally J Eder, Acham Gebremariam, et al.
Pageof 14